Cartesian Therapeutics Inc (RNAC:NASDAQ)

$8.3 0.41 (5.20%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Cartesian Therapeutics Inc (RNAC:NASDAQ) News Sources

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Yahoo Finance

Cartesian Therapeutics: Clinical Pipeline Progress Under Investor Scrutiny

aktiencheck.de

Hyderabad Biotech Utopia Therapeutics Secures US Patent for Immunotherapy-Based Obesity Vaccine

Medical Dialogues

RNAC stock
RNAC stock price
RNAC stock price today
RNAC stock prediction
RNAC earnings date
RNAC news
RNAC price
RNAC share
RNAC share price
RNAC shares
RNAC ceo
RNAC premarket
$RNAC
RNAC ticker
RNAC after hours
RNAC stock
RNAC stock price
RNAC stock price today
RNAC stock prediction
RNAC earnings date
RNAC news
RNAC price
RNAC share
RNAC share price
RNAC shares
RNAC ceo
RNAC premarket
$RNAC
RNAC ticker
RNAC after hours

Cartesian Therapeutics Inc (RNAC:NASDAQ) FAQs

toggle

What is the current price of Cartesian Therapeutics Inc (RNAC:NASDAQ)?

The current price of Cartesian Therapeutics Inc (RNAC:NASDAQ) is $8.3.


toggle

Cartesian Therapeutics Inc (RNAC:NASDAQ) absolute price change since previous trading day?

The absolute price change of Cartesian Therapeutics Inc (RNAC:NASDAQ) since the previous trading day is $0.41.


toggle

Cartesian Therapeutics Inc (RNAC:NASDAQ) percentage price change since previous trading day?

The percentage price change of Cartesian Therapeutics Inc (RNAC:NASDAQ) since the previous trading day is 5.20%.


toggle

What is This Week's average sentiment score for Cartesian Therapeutics Inc (RNAC:NASDAQ)?

This Week's average sentiment score for Cartesian Therapeutics Inc (RNAC:NASDAQ) is 86 out of 100.


toggle

What is This Week's average sentiment for Cartesian Therapeutics Inc (RNAC:NASDAQ)?

This Week's sentiment for Cartesian Therapeutics Inc (RNAC:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.